Noun
sarilumab (uncountable)
(pharmacology) A human monoclonal antibody against the interleukin-6 receptor. Used to attenuate counterproductive immune responses in certain diseases (autoimmune or infectious).
Several drugs that target inflammatory cytokines are in clinical development for Covid-19, including anti-IL-6 monoclonal antibodies like Actemra (tocilizumab) and Regeneron Pharmaceuticals Kevzara (sarilumab). Source: Internet
Other drugs currently in clinical development for Covid-19 include Regeneron Pharmaceuticals Kevzara (sarilumab). Source: Internet